跳至主要内容
临床试验/IRCT138802091859N1
IRCT138802091859N1已完成2 期

Evaluation of the saffron effect on improvement of physical and cognitive symptoms in patients with Multiple Sclerosis compared with the placebo

Vice President, Science and Technology Branch0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • 1. Patients with Relapsing- Remitting Multiple Sclerosis based on McDonald's Criteria 2.age between 18-50 years old 3. Expanded Disability Status Scale (EDSS) 0- 5.5 4. Under treatment with Betaferon or Extavia 5. Signing consent form. -Exclusion criteria: 1. Being pregnant during trial or intention to get pregnant in start of trial 2.Psychiatric disease or major depression 3. Allergy or hypersensitivity reaction to Saffron in the start of trial 4. Treatment with Intravenous immunoglobulin (IVIG) within six months prior to trial 5.Impaired Liver Function Tests (more than three times normal range) 6. Lack of medication more than four weeks.

排除标准

  • 未提供

研究者

发起方
Vice President, Science and Technology Branch

相似试验

Saffron in treatment of Multiple Sclerosis | 临床试验